16.11.2023 16:30
The Fongit Innovation Fund (FIF) has awarded three Geneva-based life science projects for their groundbreaking innovations. A CHF 100,000 seed loan has been granted to TheraPPI Bioscience, whose technology addresses drug-resistant cancers and non-curable rare diseases. A second seed loan of CHF 100,000 has been awarded to MPC Therapeutics SA, a University of Geneva spinoff, for their work on fighting degenerative diseases through cellular rejuvenation. A CHF 50,000 grant has also been awarded to dEEgtal, a project of the University of Geneva, for their innovation using artificial intelligence to improve epilepsy diagnosis.